Delivery Order SPE2DB24D1205-SPE2DB25FCWUC

Award Date 5/14/25
Potential Completion Date 6/5/25
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,771.04, is for the delivery of the prescription medication Orgovyx 120 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period through May 16, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Orgovyx 120 mg tablets. The contract has a firm fixed price of $1,385.52 and a period of performance through May 29, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $1,385.52, is for the pharmaceutical product Orgovyx 120 mg tablets. The contract is a firm fixed-price delivery order and is not set aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,313.12, is for the delivery of Orgovyx 120 mg tablets over a period ending on June 2, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Orgovyx 120 mg tablets, a specialty medication, and has a ceiling value of $2,659.78. The contract is a firm fixed-price delivery order with a completion date of November 27, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DB24D2018|SPE2DB25FWUH1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Orgovyx 120 mg tablets. The contract has a ceiling value of $1,385.52 and a period of performance through May 19, 2025. This appears to be a delivery order, with a firm fixed-price pricing type, and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 30-count bottles of the prescription medication Orgovyx 120 mg tablets, with a ceiling value of $6,927.60 and a period of performance through May 27, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Orgovyx 120 mg tablets. The order has a completion date of March 14, 2024 and a potential value of $3,989.67. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of the pharmaceutical product Orgovyx 120 mg Tablet, with a ceiling value of $7,979.34 and a period of performance through May 24, 2024. Amerisourcebergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The $1,329.89 award is for the supply of Orgovyx 120 mg tablets, a specialty pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of an Indefinite Delivery Contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCWUC
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Orgovyx 120 mg tablets. The contract has a ceiling value of $2,771.04 and a period of performance through June 5, 2025. It is a firm-fixed-price contract type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs through December 2026. This delivery order is not set aside and represents an open competition award to AmerisourceBergen Drug Corp to supply the specified pharmaceutical product to the Defense Logistics Agency.

Generated 8/13/25, 10:44 AM